(redirected from Immunosuppressants)
Also found in: Thesaurus, Medical, Encyclopedia.


 (ĭm′yə-nō-sə-prĕsh′ən, ĭ-myo͞o′-)
Suppression of the immune response, as by drugs or radiation, in order to prevent the rejection of grafts or transplants or to control autoimmune diseases. Also called immunodepression.

im′mu·no·sup·pres′sant (-prĕs′ənt) n.
im′mu·no·sup·pressed′ (-prĕst′) adj.
im′mu·no·sup·pres′sive adj.


(Medicine) medical suppression of the body's immune system, esp in order to reduce the likelihood of rejection of a transplanted organ


(ˌɪm yə noʊ səˈprɛʃ ən, ɪˌmyu-)

the inhibition of the normal immune response because of disease, the administration of drugs, or surgery.
im`mu•no•sup•press′, v.t. -pressed, -press•ing.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunosuppression - lowering the body's normal immune response to invasion by foreign substances; can be deliberate (as in lowering the immune response to prevent rejection of a transplanted organ) or incidental (as a side effect of radiotherapy or chemotherapy for cancer)
immunological disorder - a disorder of the immune system


[ɪˈmjʊːnəʊsəˈpreʃən] Ninmunosupresión f


n inmunosupresión f
References in periodicals archive ?
branded as Envarsus XR (tacrolimus extended-release tablets) for prophylaxis of organ rejection in kidney transplant patients converted from tacrolimus immediate release formulations in combination with other immunosuppressants.
Prior Information Notice: Medicines containing immunosuppressants.
The analysis revealed that the blood samples from participants had well-controlled HIV remainders from transplantation to long-term exposure to immunosuppressants.
Due to uneven implementation of this informal guidance, Congress enacted Section 176 of the Medicare Improvements for Patients and Providers Act (MIPPA) which established statutory protection for immunosuppressants and five other protected classes of drugs under Medicare Part D, requiring Medicare Part D drug pans to include in their formularies access to all or substantially all drugs in the six identified classes.
ULTRA 1 was an eight week, multi-center, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of HUMIRA for the induction of clinical remission per Mayo score in 390 anti-TNF naive adult patients who had moderately to severely active UC despite concurrent or prior treatment with immunosuppressants (i.
In contrast to methotrexate, the number of samples processed for other immunosuppressants with the immunosuppressant assay is high enough to support the LC-MS/MS infrastructure in many laboratories.
The company has identified biosimilars, immunosuppressants, research services and the emerging markets as key growth drivers in the near future, she added.
This is particularly alarming because many of these women appear to be at increased risk for abnormal cervical cytology because they take immunosuppressants to control the inflammatory bowel disease (IBD), wrote Dr.
Conventional treatment with immunosuppressants is usually recommended for this disease, but when these fail to work, there is a lack of suitable alternative therapy except long-term steroids.
The use of an antigen-specific technology to regulate the immune response and the T-cells causing disease has a distinct advantage over the use of non-specific immunosuppressants because the AdapT technology should limit or even eliminate the unwanted side effects of the currently available immunosuppressant drugs.
Other recent research may lead to improved dosing for the immunosuppressants cyclosporine and tactolimus, which can cause kidney damage and failure.
LIVING WITH LUPUS: Learn about the latest treatments, including immunosuppressants (chemotherapy), for the autoimmune disease lupus at the Living With Lupus patient symposium.